Past and recent progress of molecular imaging probes for β-amyloid plaques in the brain

Current Medicinal Chemistry

Volumn 21, Issue 1, 2014, Pages 82-112

  Cui, Mengchao ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

Author keywords

amyloid; Alzheimer's disease; Brain; Imaging probe; Molecular imaging; Near infrared; Optical imaging; Plaque; Positron emission tomography; Single photon emission computed tomography.

Indexed keywords

1,4 DIPHENYLTRIAZOLE DERIVATIVE FLUORINE 18; ACRIDINE DERIVATIVE IODINE 125; AZD 4694 FLUORINE 18; AZO DYE; BENZOFURAN DERIVATIVE CARBON 11; BENZOFURAN DERIVATIVE IODINE 125; BENZOIMIDAZOLE DERIVATIVE IODINE 125; BENZOTHIAZOLE DERIVATIVE IODINE 125; BENZOTHIAZOLE DERIVATIVE TECHNETIUM 99M; BIPHENYL DERIVATIVE TECHNETIUM 99M; CHALCONE DERIVATIVE IODINE 125; CHALCONE DERIVATIVE TECHNETIUM 99M; CONGO RED; CRYSTAMINE G IODINE 125; CURCUMIN FLUORINE 18; DIPHENYLPROPYNONE DERIVATIVE IODINE 125; FLAVONE DERIVATIVE FLUORINE 18; FLORBETABEN; FLORBETAPIR F 18; FLUORINE 18; INDANONE DERIVATIVE IODINE 125; IODINE 125; NAPTHPHEN DERIVATIVE FLUORINE 18; PHENYLBENZOFURAN DERIVATIVE TECHNETIUM 99M; RADIOPHARMACEUTICAL AGENT; STILBENE DERIVATIVE FLUORINE 18; STILBENE DERIVATIVE TECHNETIUM 99M; TECHNETIUM 99M; THIOFLAVINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; DRUG HALF LIFE; EARLY DIAGNOSIS; FLUORESCENCE IMAGING; HUMAN; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; MOLECULAR WEIGHT; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SENILE PLAQUE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BRAIN; FLUORESCENT DYES; HUMANS; ISOTOPE LABELING; MOLECULAR IMAGING; MOLECULAR PROBES; PLAQUE, AMYLOID;

EID: 84889610430     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990216     Document Type: Article

References (223)

1. Association., A.P. Diagnostic and statistical manual of mental disorders, 4th ed.; American Psychiatric Association: Washington, DC, 2000.
2. Wimo, A.; Winblad, B.; Jonsson, L. An Estimate of the Total Worldwide Societal Costs of Dementia in 2005. Alzheimers Dement., 2007, 3(2), 81-91. (Pubitemid 46586163)
3. Selkoe, D.J. The origins of Alzheimer disease: a is for amyloid. JAMA., 2000, 283(12), 1615-1617. (Pubitemid 30161520)
4. Wimo, A.; Winblad, B.; Aguero-Torres, H.; von Strauss, E. The magnitude of dementia occurrence in the world. Alzheimer Dis. Assoc. Disord., 2003, 17(2), 63-67. (Pubitemid 36736838)
5. Brookmeyer, R.; Johnson, E.; Ziegler-Graham, K.; Arrighi, H.M. Forecasting the Global Burden of Alzheimer's Disease. Alzheimers Dement., 2007, 3(3), 186-191. (Pubitemid 46825511)
6. Tabert, M.H.; Liu, X.; Doty, R.L.; Serby, M.; Zamora, D.; Pelton, G.H.; Marder, K.; Albers, M.W.; Stern, Y.; Devanand, D.P. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann. Neurol., 2005, 58(1), 155-160. (Pubitemid 40962473)
7. Kung, H.F. The β-Amyloid hypothesis in Alzheimer's disease: seeing is believing. ACS Med. Chem. Lett., 2012, 3(4), 265-267.
8. McKhann, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; Stadlan, E.M. Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 1984, 34(7), 939-944. (Pubitemid 14076461)
9. Dubois, B.; Feldman, H.H.; Jacova, C.; Dekosky, S.T.; Barberger-Gateau, P.; Cummings, J.; Delacourte, A.; Galasko, D.; Gauthier, S.; Jicha, G.; Meguro, K.; O'Brien, J.; Pasquier, F.; Robert, P.; Rossor, M.; Salloway, S.; Stern, Y.; Visser, P.J.; Scheltens, P. Research Criteria for the Diagnosis of Alzheimer's Disease: Revising the NINCDS-ADRDA Criteria. Lancet Neurol., 2007, 6(8), 734-746. (Pubitemid 47058377)
10. Mendez, M.F. The accurate diagnosis of early-onset dementia. Int. J. Psychiatry Med., 2006, 36(4), 401-412. (Pubitemid 47105277)
11. Berchtold, N.C.; Cotman, C.W. Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s. Neurobiol. Aging, 1998, 19(3), 173-189. (Pubitemid 128714320)
12. Terry, R.D.; Gonatas, N.K.; Weiss, M. Ultrastructural Studies in Alzheimer's Presenile Dementia. Am. J. Pathol., 1964, 44, 269-297.
13. Glenner, G.G.; Wong, C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun., 1984, 120(3), 885-890. (Pubitemid 14104991)
14. Hardy, J.A.; Higgins, G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science, 1992, 256(5054), 184-185.
15. Hardy, J.; Selkoe, D.J. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics. Science, 2002, 297(5580), 353-356. (Pubitemid 34790756)
16. Hardy, J. Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J. Alzheimers Dis., 2006, 9(3 Suppl), 151-153. (Pubitemid 44253307)
17. Hardy, J.; Allsop, D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci., 1991, 12(10), 383-388.
18. Bamberger, M.E.; Landreth, G.E. Microglial interaction with betaamyloid: implications for the pathogenesis of Alzheimer's disease. Microsc. Res. Tech., 2001, 54(2), 59-70. (Pubitemid 32645871)
19. McLean, C.A.; Cherny, R.A.; Fraser, F.W.; Fuller, S.J.; Smith, M.J.; Beyreuther, K.; Bush, A.I.; Masters, C.L. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol., 1999, 46(6), 860-866.
20. Klein, W.L.; Krafft, G.A.; Finch, C.E. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci., 2001, 24(4), 219-224. (Pubitemid 32204378)
21. Caricasole, A.; Copani, A.; Caruso, A.; Caraci, F.; Iacovelli, L.; Sortino, M.A.; Terstappen, G.C.; Nicoletti, F. The Wnt Pathway, Cell-cycle Activation and Beta-amyloid: Novel Therapeutic Strategies in Alzheimer's Disease? Trends Pharmacol. Sci., 2003, 24(5), 233-238. (Pubitemid 36588871)
22. Cataldo, A.M.; Petanceska, S.; Terio, N.B.; Peterhoff, C.M.; Durham, R.; Mercken, M.; Mehta, P.D.; Buxbaum, J.; Haroutunian, V.; Nixon, R.A. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol. Aging, 2004, 25(10), 1263-1272. (Pubitemid 39299162)
23. Gotz, J.; Streffer, J.R.; David, D.; Schild, A.; Hoerndli, F.; Pennanen, L.; Kurosinski, P.; Chen, F. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Mol. Psychiatry, 2004, 9(7), 664-683. (Pubitemid 38932172)
24. Hsiao, K.; Chapman, P.; Nilsen, S.; Eckman, C.; Harigaya, Y.; Younkin, S.; Yang, F.; Cole, G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science, 1996, 274(5284), 99-102. (Pubitemid 26332733)
25. Nordberg, A. Amyloid plaque imaging in vivo: current achievement and future prospects. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35 Supp. 1, S46-S50.
26. Golde, T.E.; Bacskai, B.J. Bringing amyloid into focus. Nat. Biotech., 2005, 23(5), 552-554. (Pubitemid 41724891)
27. Cai, L.; Innis, R.B.; Pike, V.W. Radioligand development for PET imaging of beta-amyloid (Abeta)-current status. Curr. Med. Chem., 2007, 14(1), 19-52. (Pubitemid 46050302)
28. Stains, C.I.; Mondal, K.; Ghosh, I. Molecules that target betaamyloid. Chem. Med. Chem., 2007, 2(12), 1674-1692.
29. Henriksen, G.; Yousefi, B.H.; Drzezga, A.; Wester, H.J. Development and evaluation of compounds for imaging of betaamyloid plaque by means of positron emission tomography. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35 Suppl 1, S75-S81.
30. Quigley, H.; Colloby, S.J.; O'Brien, J.T. PET imaging of brain amyloid in dementia: a review. Int. J. Geriatr. Psychiatry, 2011, 26(10), 991-999.
31. Rowe, C.C.; Villemagne, V.L. Brain amyloid imaging. J. Nucl. Med., 2011, 52(11), 1733-1740.
32. Vallabhajosula, S., Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid. Semin. Nucl. Med., 2011, 41(4), 283-299.
33. Mathis, C.A.; Mason, N.S.; Lopresti, B.J.; Klunk, W.E. Development of positron emission tomography beta-amyloid plaque imaging agents. Semin. Nucl. Med., 2012, 42(6), 423-432.
34. Svedberg, M.M.; Rahman, O.; Hall, H. Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease. Nucl. Med. Biol., 2012, 39(4), 484-501.
35. Ametamey, S.M.; Honer, M.; Schubiger, P.A. Molecular imaging with PET. Chem. Rev., 2008, 108(5), 1501-1516. (Pubitemid 351796395)
36. Kung, H.F.; Choi, S.R.; Qu, W.; Zhang, W.; Skovronsky, D. 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective. J. Med. Chem., 2010, 53(3), 933-941.
37. Syvanen, S.; Eriksson, J. Advances in PET imaging of pglycoprotein function at the blood-brain barrier. ACS Chem. Neurosci., 2013, 4(2), 225-237.
38. Ntziachristos, V.; Ripoll, J.; Wang, L.V.; Weissleder, R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol., 2005, 23(3), 313-320. (Pubitemid 41094419)
39. Ntziachristos, V. Fluorescence molecular imaging. Annu. Rev. Biomed. Eng., 2006, 8, 1-33. (Pubitemid 44314811)
40. Weissleder, R.; Ntziachristos, V. Shedding light onto live molecular targets. Nat. Med., 2003, 9(1), 123-128. (Pubitemid 36098273)
41. Frangioni, J.V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol., 2003, 7(5), 626-634. (Pubitemid 37315800)
42. Ntziachristos, V.; Bremer, C.; Weissleder, R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur. Radiol., 2003, 13(1), 195-208. (Pubitemid 36790510)
43. Ran, C.; Xu, X.; Raymond, S.B.; Ferrara, B.J.; Neal, K.; Bacskai, B.J.; Medarova, Z.; Moore, A. Design, synthesis, and testing of difluoroboron- derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits. J. Am. Chem. Soc., 2009, 131(42), 15257-15261.
44. Nesterov, E.E.; Skoch, J.; Hyman, B.T.; Klunk, W.E.; Bacskai, B.J.; Swager, T.M. In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers. Angew. Chem. Int. Ed. Engl., 2005, 44(34), 5452-5456. (Pubitemid 41273293)
45. Klunk, W.E.; Debnath, M.L.; Pettegrew, J.W. Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe. Neurobiol. Aging, 1995, 16(4), 541-548.
46. Lee, C.W.; Zhuang, Z.P.; Kung, M.P.; Plossl, K.; Skovronsky, D.; Gur, T.; Hou, C.; Trojanowski, J.Q.; Lee, V.M.; Kung, H.F. Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain. J. Med. Chem., 2001, 44(14), 2270-2275. (Pubitemid 32867395)
47. Kung, M.P.; Hou, C.; Zhuang, Z.P.; Skovronsky, D.M.; Zhang, B.; Gur, T.L.; Trojanowski, J.Q.; Lee, V.M.; Kung, H.F. Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease. J. Mol. Neurosci., 2002, 19(1-2), 7-10. (Pubitemid 35013327)
48. Wang, Y.; Mathis, C. A.; Huang, G.-F.; Holt, D. P.; Debnath, M. L.; Klunk, W. E. Synthesis and 11C-labelling of (E,E)-1-(3',4'-dihydroxystyryl)-4- (3'-methoxy-4'-hydroxystyryl) benzene for PET imaging of amyloid deposits. J. Label. Compd. Radiopharm., 2002, 45, 647-664. (Pubitemid 34839253)
49. Jacobson, A.; Petric, A.; Hogenkamp, D.; Sinur, A.; Barrio, J.R. 1,1-Dicyano-2-[6-(dimethylamino)naphthalen-2-yl]propene (DDNP): a solvent polarity and viscosity sensitive fluorophore for fluorescence microscopy. J. Am. Chem. Soc., 1996, 118(24), 5572-5579. (Pubitemid 26233644)
50. Agdeppa, E.D.; Kepe, V.; Liu, J.; Flores-Torres, S.; Satyamurthy, N.; Petric, A.; Cole, G.M.; Small, G.W.; Huang, S.C.; Barrio, J.R. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J. Neurosci., 2001, 21(24), RC189.
51. Agdeppa, E.D.; Kepe, V.; Liu, J.; Small, G.W.; Huang, S.C.; Petric, A.; Satyamurthy, N.; Barrio, J.R. 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. Mol. Imaging Biol., 2003, 5(6), 404-417. (Pubitemid 37489831)
52. Shoghi-Jadid, K.; Small, G.W.; Agdeppa, E.D.; Kepe, V.; Ercoli, L.M.; Siddarth, P.; Read, S.; Satyamurthy, N.; Petric, A.; Huang, S.C.; Barrio, J.R. Localization of neurofibrillary tangles and betaamyloid plaques in the brains of living patients with Alzheimer disease. Am. J. Geriatr. Psychiatry., 2002, 10(1), 24-35. (Pubitemid 34052900)
53. Thompson, P.W.; Ye, L.; Morgenstern, J.L.; Sue, L.; Beach, T.G.; Judd, D.J.; Shipley, N.J.; Libri, V.; Lockhart, A. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies. J. Neurochem., 2009, 109(2), 623-630.
54. Styren, S.D.; Hamilton, R.L.; Styren, G.C.; Klunk, W.E. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J. Histochem. Cytochem., 2000, 48(9), 1223-1232.
55. Klunk, W.E.; Bacskai, B.J.; Mathis, C.A.; Kajdasz, S.T.; McLellan, M.E.; Frosch, M.P.; Debnath, M.L.; Holt, D.P.; Wang, Y.; Hyman, B.T. Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J. Neuropathol. Exp. Neurol., 2002, 61(9), 797-805. (Pubitemid 35001352)
56. Zhuang, Z.P.; Kung, M.P.; Hou, C.; Skovronsky, D.M.; Gur, T.L.; Plossl, K.; Trojanowski, J.Q.; Lee, V.M.; Kung, H.F. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J. Med. Chem., 2001, 44(12), 1905-1914. (Pubitemid 32884515)
57. Wolfe, L.S.; Calabrese, M.F.; Nath, A.; Blaho, D.V.; Miranker, A.D.; Xiong, Y. Protein-induced photophysical changes to the amyloid indicator dye thioflavin T. Proc. Natl. Acad. Sci. U.S.A., 2010, 107(39), 16863-16868.
58. Klunk, W.E.; Wang, Y.; Huang, G.F.; Debnath, M.L.; Holt, D.P.; Mathis, C.A. Uncharged Thioflavin-T Derivatives Bind to Amyloidbeta Protein with High Affinity and Readily Enter the Brain. Life Sci., 2001, 69(13), 1471-1484. (Pubitemid 32786721)
59. Mathis, C.A.; Wang, Y.; Holt, D.P.; Huang, G.F.; Debnath, M.L.; Klunk, W.E. Synthesis and evaluation of [11C]-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J. Med. Chem., 2003, 46(13), 2740-2754. (Pubitemid 36702542)
60. Henriksen, G.; Hauser, A.I.; Westwell, A.D.; Yousefi, B.H.; Schwaiger, M.; Drzezga, A.; Wester, H.J. Metabolically stabilized benzothiazoles for imaging of amyloid plaques. J. Med. Chem., 2007, 50(6), 1087-1089. (Pubitemid 46496309)
61. Mathis, C.A.; Bacskai, B.J.; Kajdasz, S.T.; McLellan, M.E.; Frosch, M.P.; Hyman, B.T.; Holt, D.P.; Wang, Y.; Huang, G.F.; Debnath, M.L.; Klunk, W.E. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg. Med. Chem. Lett., 2002, 12(3), 295-298. (Pubitemid 34113887)
62. Klunk, W.E.; Engler, H.; Nordberg, A.; Wang, Y.; Blomqvist, G.; Holt, D.P.; Bergstrom, M.; Savitcheva, I.; Huang, G.F.; Estrada, S.; Ausen, B.; Debnath, M.L.; Barletta, J.; Price, J.C.; Sandell, J.; Lopresti, B.J.; Wall, A.; Koivisto, P.; Antoni, G.; Mathis, C.A.; Langstrom, B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol., 2004, 55(3), 306-319. (Pubitemid 38269583)
63. Kadir, A.; Marutle, A.; Gonzalez, D.; Scholl, M.; Almkvist, O.; Mousavi, M.; Mustafiz, T.; Darreh-Shori, T.; Nennesmo, I.; Nordberg, A. Positron Emission Tomography Imaging and Clinical Progression in Relation to Molecular Pathology in the First Pittsburgh Compound B Positron Emission Tomography Patient with Alzheimer's Disease. Brain, 2011, 134(Pt 1), 301-317.
64. Ikonomovic, M.D.; Klunk, W.E.; Abrahamson, E.E.; Mathis, C.A.; Price, J.C.; Tsopelas, N.D.; Lopresti, B.J.; Ziolko, S.; Bi, W.; Paljug, W.R.; Debnath, M.L.; Hope, C.E.; Isanski, B.A.; Hamilton, R.L.; DeKosky, S.T. Post-mortem Correlates of in Vivo PIB-PET Amyloid Imaging in A Typical Case of Alzheimer's Disease. Brain, 2008, 131(Pt 6), 1630-1645. (Pubitemid 351806448)
65. Andersson, J.D.; Varnas, K.; Cselenyi, Z.; Gulyas, B.; Wensbo, D.; Finnema, S.J.; Swahn, B.M.; Svensson, S.; Nyberg, S.; Farde, L.; Halldin, C. Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys. Synapse, 2010, 64(10), 733-741.
66. Nyberg, S.; Jonhagen, M.E.; Cselenyi, Z.; Halldin, C.; Julin, P.; Olsson, H.; Freund-Levi, Y.; Andersson, J.; Varnas, K.; Svensson, S.; Farde, L. Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36(11), 1859-1863.
67. Johnson, A.E.; Jeppsson, F.; Sandell, J.; Wensbo, D.; Neelissen, J.A.; Jureus, A.; Strom, P.; Norman, H.; Farde, L.; Svensson, S.P. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. J. Neurochem., 2009, 108(5), 1177-1186.
68. Zheng., M.-Q.; Yina., D.-Z.; Qiao., J.-P.; Zhang., L.; Wang., Y.-X. Syntheses and evaluation of fluorinated benzothiazole anilines as potential tracers for β-amyloid plaques in Alzheimer's disease. J. Fluorine Chem., 2008, 129(3), 210-216.
69. Berndt, U.; Stanetty, C.; Wanek, T.; Kuntner, C.; Stanek, J.; Berger, M.; Bauer, M.; Henriksen, G.; Wester, H.-J.; Kvaternik, H.; Angelberger, P.; Noe, C. Synthesis of a [18F]fluorobenzothiazole as potential amyloid imaging agent. J. Labelled Compd. Radiopharm., 2008, 51(3), 137-145. (Pubitemid 351642432)
70. Neumaier, B.; Deisenhofer, S.; Sommer, C.; Solbach, C.; Reske, S.N.; Mottaghy, F. Synthesis and evaluation of 18F-fluoroethylated benzothiazole derivatives for in vivo imaging of amyloid plaques in Alzheimer's disease. Appl. Radiat. Isot., 2010, 68(6), 1066-1072.
71. Serdons, K.; Vanderghinste, D.; Van Eeckhoudt, M.; Borghgraef, P.; Kung, H.; Van Leuven, F.; de Groot, T.; Bormans, G.; Verbruggen, A. Synthesis and evaluation of two fluorine-18 labelled phenylbenzothiazoles as potential in vivo tracers for amyloid plaque imaging. J. Labelled Compd. Radiopharm., 2009, 52(11), 473-481.
72. Stephenson, K.A.; Chandra, R.; Zhuang, Z.P.; Hou, C.; Oya, S.; Kung, M.P.; Kung, H.F. Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregates. Bioconjug. Chem., 2007, 18(1), 238-246. (Pubitemid 46146015)
73. Cui, M.; Wang, X.; Yu, P.; Zhang, J.; Li, Z.; Zhang, X.; Yang, Y.; Ono, M.; Jia, H.; Saji, H.; Liu, B. Synthesis and evaluation of novel (18)F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of beta-amyloid plaques. J. Med. Chem., 2012, 55(21), 9283-9296.
74. Mathis., C.; Lopresti., B.; Mason., N.; Price., J.; Flatt., N.; Bi., W.; Ziolko., S.; DeKosky., S.; Klunk., W. Comparison of the amyloid imaging agents F-183'-F-PIB and C-11PIB in Alzheimer's disease and control subjects. J. Nucl. Med., 2007, 48(Supplement 2), 56P.
75. Koole, M.; Lewis, D.M.; Buckley, C.; Nelissen, N.; Vandenbulcke, M.; Brooks, D.J.; Vandenberghe, R.; Van Laere, K. Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J. Nucl. Med., 2009, 50(5), 818-822.
76. Vandenberghe, R.; Van Laere, K.; Ivanoiu, A.; Salmon, E.; Bastin, C.; Triau, E.; Hasselbalch, S.; Law, I.; Andersen, A.; Korner, A.; Minthon, L.; Garraux, G.; Nelissen, N.; Bormans, G.; Buckley, C.; Owenius, R.; Thurfjell, L.; Farrar, G.; Brooks, D.J. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann. Neurol., 2010, 68(3), 319-329.
77. Thurfjell, L.; Lotjonen, J.; Lundqvist, R.; Koikkalainen, J.; Soininen, H.; Waldemar, G.; Brooks, D.J.; Vandenberghe, R. Combination of biomarkers: PET 18F-flutemetamol imaging and structural MRI in dementia and mild cognitive impairment. Neurodegener. Dis., 2012, 10(1-4), 246-249.
78. Serdons, K.; Verduyckt, T.; Vanderghinste, D.; Cleynhens, J.; Borghgraef, P.; Vermaelen, P.; Terwinghe, C.; Van Leuven, F.; Van Laere, K.; Kung, H.; Bormans, G.; Verbruggen, A. Synthesis of 18F-labelled 2-(4'-fluorophenyl)-1,3- benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB. Bioorg. Med. Chem. Lett., 2009, 19(3), 602-605.
79. Serdons, K.; Van Laere, K.; Janssen, P.; Kung, H.F.; Bormans, G.; Verbruggen, A. Synthesis and evaluation of three 18F-labeled aminophenylbenzothiazoles as amyloid imaging agents. J. Med. Chem., 2009, 52(22), 7090-7102.
80. Zhuang, Z.P.; Kung, M.P.; Hou, C.; Plossl, K.; Skovronsky, D.; Gur, T.L.; Trojanowski, J.Q.; Lee, V.M.; Kung, H.F. IBOX(2-(4'-dimethylaminophenyl)-6- iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Nucl. Med. Biol., 2001, 28(8), 887-894. (Pubitemid 33050020)
81. Hausner, S.H.; Alagille, D.; Koren, A.O.; Amici, L.; Staley, J.K.; Cosgrove, K.P.; Baldwin, R.M.; Tamagnan, G.D. Synthesis of 5-and 6-substituted 2-(4-dimethylaminophenyl)-1,3-benzoxazoles and their in vitro and in vivo evaluation as imaging agents for amyloid plaque. Bioorg. Med. Chem. Lett., 2009, 19(2), 543-545.
82. Swahn, B.M.; Wensbo, D.; Sandell, J.; Sohn, D.; Slivo, C.; Pyring, D.; Malmstrom, J.; Arzel, E.; Vallin, M.; Bergh, M.; Jeppsson, F.; Johnson, A.E.; Jureus, A.; Neelissen, J.; Svensson, S. Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as [11C]-PET imaging agents for betaamyloid plaques. Bioorg. Med. Chem. Lett., 2010, 20(6), 1976-1980.
83. Swahn, B.M.; Sandell, J.; Pyring, D.; Bergh, M.; Jeppsson, F.; Jureus, A.; Neelissen, J.; Johnstrom, P.; Schou, M.; Svensson, S. Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as (18)FPET imaging agents for beta-amyloid plaques. Bioorg. Med. Chem. Lett., 2012, 22(13), 4332-4337.
84. Cui, M.; Ono, M.; Kimura, H.; Ueda, M.; Nakamoto, Y.; Togashi, K.; Okamoto, Y.; Ihara, M.; Takahashi, R.; Liu, B.; Saji, H. Novel (18)F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral beta-amyloid plaques in Alzheimer's disease. J. Med. Chem., 2012, 55(21), 9136-9145.
85. Ono, M.; Kung, M.P.; Hou, C.; Kung, H.F. Benzofuran derivatives as Abeta-aggregate-specific imaging agents for Alzheimer's disease. Nucl. Med. Biol., 2002, 29(6), 633-642. (Pubitemid 35266662)
86. Ono, M.; Kawashima, H.; Nonaka, A.; Kawai, T.; Haratake, M.; Mori, H.; Kung, M.P.; Kung, H.F.; Saji, H.; Nakayama, M. Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains. J. Med. Chem., 2006, 49(9), 2725-2730.
87. Cheng, Y.; Ono, M.; Kimura, H.; Kagawa, S.; Nishii, R.; Kawashima, H.; Saji, H. Fluorinated benzofuran derivatives for PET imaging of β-Amyloid plaques in alzheimer's disease brains. ACS Med. Chem. Lett., 2010, 1(7), 321-325.
88. Cheng, Y.; Ono, M.; Kimura, H.; Kagawa, S.; Nishii, R.; Saji, H. A novel 18F-labeled pyridyl benzofuran derivative for imaging of beta-amyloid plaques in Alzheimer's brains. Bioorg. Med. Chem. Lett., 2010, 20(20), 6141-6144.
89. Ono, M.; Cheng, Y.; Kimura, H.; Cui, M.; Kagawa, S.; Nishii, R.; Saji, H. Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of beta-amyloid plaques in Alzheimer's brains. J. Med. Chem., 2011, 54(8), 2971-2979.
90. Jureus, A.; Swahn, B.M.; Sandell, J.; Jeppsson, F.; Johnson, A.E.; Johnstrom, P.; Neelissen, J.A.; Sunnemark, D.; Farde, L.; Svensson, S.P. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand. J. Neurochem., 2010, 114(3), 784-794.
91. Cselenyi, Z.; Jonhagen, M.E.; Forsberg, A.; Halldin, C.; Julin, P.; Schou, M.; Johnstrom, P.; Varnas, K.; Svensson, S.; Farde, L. Clinical validation of 18F-AZD4694, an amyloid-beta-specific PET radioligand. J. Nucl. Med., 2012, 53(3), 415-424.
92. Chang, Y.S.; Jeong, J.M.; Lee, Y.S.; Kim, H.W.; Ganesha, R.B.; Kim, Y.J.; Lee, D.S.; Chung, J.K.; Lee, M.C. Synthesis and evaluation of benzothiophene derivatives as ligands for imaging beta-amyloid plaques in Alzheimer's disease. Nucl. Med. Biol., 2006, 33(6), 811-820. (Pubitemid 44247742)
93. Watanabe, H.; Ono, M.; Haratake, M.; Kobashi, N.; Saji, H.; Nakayama, M. Synthesis and characterization of novel phenylindoles as potential probes for imaging of beta-amyloid plaques in the brain. Bioorg. Med. Chem., 2010, 18(13), 4740-4746.
94. Cui, M.; Ono, M.; Kimura, H.; Kawashima, H.; Liu, B.L.; Saji, H. Radioiodinated benzimidazole derivatives as single photon emission computed tomography probes for imaging of betaamyloid plaques in Alzheimer's disease. Nucl. Med. Biol., 2011, 38(3), 313-320.
95. Kung, M.P.; Hou, C.; Zhuang, Z.P.; Zhang, B.; Skovronsky, D. Trojanowski, J.Q.; Lee, V.M.; Kung, H.F., IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques. Brain Res., 2002, 956(2), 202-210. (Pubitemid 35351385)
96. Kung, M.P.; Hou, C.; Zhuang, Z.P.; Skovronsky, D.; Kung, H.F. Binding of Two Potential Imaging Agents Targeting Amyloid Plaques in Postmortem Brain Tissues of Patients with Alzheimer's Disease. Brain Res., 2004, 1025(1-2), 98-105. (Pubitemid 39359172)
97. Kung, M.P.; Hou, C.; Zhuang, Z.P.; Cross, A.J.; Maier, D.L.; Kung, H.F. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice. Eur. J. Nucl. Med. Mol. Imaging, 2004, 31(8), 1136-1145. (Pubitemid 39050181)
98. Zhuang, Z.P.; Kung, M.P.; Wilson, A.; Lee, C.W.; Plossl, K.; Hou, C.; Holtzman, D.M.; Kung, H.F. Structure-activity relationship of imidazo1,2-apyridines as ligands for detecting beta-amyloid plaques in the brain. J. Med. Chem., 2003, 46(2), 237-243. (Pubitemid 36078143)
99. Kung, M.P.; Weng, C.C.; Lin, K.J.; Hsiao, I.T.; Yen, T.C.; Wey, S.P. Amyloid plaque imaging from IMPY/SPECT to AV-45/PET. Chang Gung Med. J., 2012, 35(3), 211-218.
100. Newberg, A.B.; Wintering, N.A.; Plossl, K.; Hochold, J.; Stabin, M.G.; Watson, M.; Skovronsky, D.; Clark, C.M.; Kung, M.P.; Kung, H.F. Safety, biodistribution, and dosimetry of [123I]-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. J. Nucl. Med., 2006, 47(5), 748-754. (Pubitemid 46768436)
101. Cai, L.; Chin, F.T.; Pike, V.W.; Toyama, H.; Liow, J.S.; Zoghbi, S.S.; Modell, K.; Briard, E.; Shetty, H.U.; Sinclair, K.; Donohue, S.; Tipre, D.; Kung, M.P.; Dagostin, C.; Widdowson, D.A.; Green, M.; Gao, W.; Herman, M.M.; Ichise, M.; Innis, R.B. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino) phenylimidazo1,2-apyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease. J. Med. Chem., 2004, 47(9), 2208-2218. (Pubitemid 38478844)
102. Zeng, F.; Southerland, J.A.; Voll, R.J.; Votaw, J.R.; Williams, L.; Ciliax, B.J.; Levey, A.I.; Goodman, M.M. Synthesis and evaluation of two 18F-labeled imidazo1,2-apyridine analogues as potential agents for imaging beta-amyloid in Alzheimer's disease. Bioorg. Med. Chem. Lett., 2006, 16(11), 3015-3018.
103. Cai, L.; Cuevas, J.; Temme, S.; Herman, M.M.; Dagostin, C.; Widdowson, D.A.; Innis, R.B.; Pike, V.W. Synthesis and structureaffinity relationships of new 4-(6-iodo-H-imidazo1,2-apyridin-2-yl)-N-dimethylbenzeneamine derivatives as ligands for human beta-amyloid plaques. J. Med. Chem., 2007, 50(19), 4746-4758. (Pubitemid 47463247)
104. Yousefi, B.H.; Manook, A.; von Reutern, B.; Schwaiger, M.; Drzezga, A.; Wester, H.-J.; Henriksen, G. Development of an improved radioiodinated 2-phenylimidazo1,2-apyridine for noninvasive imaging of amyloid plaques. Med. Chem. Comm., 2012, 3(7), 775-779.
105. Zeng, F.; Alagille, D.; Tamagnan, G.D.; Ciliax, B.J.; Levey, A.I.; Goodman, M.M. Synthesis and in vitro evaluation of imidazo1,2-bpyridazines as ligands for β-Amyloid plaques. ACS Med. Chem. Lett., 2010, 1(2), 80-84.
106. Kung, H.F.; Lee, C.W.; Zhuang, Z.P.; Kung, M.P.; Hou, C.; Plossl, K. Novel stilbenes as probes for amyloid plaques. J. Am. Chem. Soc., 2001, 123(50), 12740-12741. (Pubitemid 33140424)
107. Ono, M.; Wilson, A.; Nobrega, J.; Westaway, D.; Verhoeff, P.; Zhuang, Z.P.; Kung, M.P.; Kung, H.F. [11C]-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease. Nucl. Med. Biol., 2003, 30(6), 565-571. (Pubitemid 37289318)
108. Verhoeff, N.P.; Wilson, A.A.; Takeshita, S.; Trop, L.; Hussey, D.; Singh, K.; Kung, H.F.; Kung, M.P.; Houle, S. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am. J. Geriatr. Psychiatry, 2004, 12(6), 584-595. (Pubitemid 41031060)
109. Zhang, W.; Oya, S.; Kung, M.P.; Hou, C.; Maier, D.L.; Kung, H.F. F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain. J. Med. Chem., 2005, 48(19), 5980-5988. (Pubitemid 41324608)
110. Zhang, W.; Oya, S.; Kung, M.P.; Hou, C.; Maier, D.L.; Kung, H.F. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. Nucl. Med. Biol., 2005, 32(8), 799-809. (Pubitemid 41505313)
111. Rowe, C.C.; Ackerman, U.; Browne, W.; Mulligan, R.; Pike, K.L.; O'Keefe, G.; Tochon-Danguy, H.; Chan, G.; Berlangieri, S.U.; Jones, G.; Dickinson-Rowe, K.L.; Kung, H.P.; Zhang, W.; Kung, M.P.; Skovronsky, D.; Dyrks, T.; Holl, G.; Krause, S.; Friebe, M.; Lehman, L.; Lindemann, S.; Dinkelborg, L.M.; Masters, C.L.; Villemagne, V.L. Imaging of Amyloid Beta in Alzheimer's Disease with 18F-BAY94-9172, A Novel PET Tracer: Proof of Mechanism. Lancet Neurol., 2008, 7(2), 129-135.
112. Barthel, H.; Gertz, H.J.; Dresel, S.; Peters, O.; Bartenstein, P.; Buerger, K.; Hiemeyer, F.; Wittemer-Rump, S.M.; Seibyl, J.; Reininger, C.; Sabri, O.; Florbetaben Study, G. Cerebral amyloidbeta PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol., 2011, 10(5), 424-435.
113. Barthel, H.; Luthardt, J.; Becker, G.; Patt, M.; Hammerstein, E.; Hartwig, K.; Eggers, B.; Sattler, B.; Schildan, A.; Hesse, S.; Meyer, P.M.; Wolf, H.; Zimmermann, T.; Reischl, J.; Rohde, B.; Gertz, H.J.; Reininger, C.; Sabri, O. Individualized quantification of brain beta-amyloid burden: results of a proof of mechanism phase0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls. Eur. J. Nucl. Med. Mol. Imaging, 2011, 38(9), 1702-1714.
114. Barthel, H.; Sabri, O. Florbetaben to trace amyloid-beta in the Alzheimer brain by means of PET. J. Alzheimers Dis., 2011, 26 Suppl 3, 117-121.
115. Fodero-Tavoletti, M.T.; Brockschnieder, D.; Villemagne, V.L.; Martin, L.; Connor, A.R.; Thiele, A.; Berndt, M.; McLean, C.A.; Krause, S.; Rowe, C.C.; Masters, C.L.; Dinkelborg, L.; Dyrks, T.; Cappai, R. In vitro characterization of 18F-florbetaben, an Abeta imaging radiotracer. Nucl. Med. Biol., 2012, 39(7), 1042-1048.
116. Ong, K.; Villemagne, V.L.; Bahar-Fuchs, A.; Lamb, F.; Chetelat, G.; Raniga, P.; Mulligan, R.S.; Salvado, O.; Putz, B.; Roth, K.; Masters, C.L.; Reininger, C.B.; Rowe, C.C. 18F-florbetaben Abeta imaging in mild cognitive impairment. Alzheimers Res. Ther., 2013, 5(1), 4.
117. Villemagne, V.L.; Ong, K.; Mulligan, R.S.; Holl, G.; Pejoska, S.; Jones, G.; O'Keefe, G.; Ackerman, U.; Tochon-Danguy, H.; Chan, J.G.; Reininger, C.B.; Fels, L.; Putz, B.; Rohde, B.; Masters, C.L.; Rowe, C.C. Amyloid imaging with 18F-florbetaben in Alzheimer disease and other dementias. J. Nucl. Med., 2011, 52(8), 1210-1217.
118. Villemagne, V.L.; Mulligan, R.S.; Pejoska, S.; Ong, K.; Jones, G.; O'Keefe, G.; Chan, J.G.; Young, K.; Tochon-Danguy, H.; Masters, C.L.; Rowe, C.C. Comparison of [11C]-PiB and 18F-florbetaben for Abeta imaging in ageing and Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging, 2012, 39(6), 983-989.
119. Ono, M.; Haratake, M.; Nakayama, M.; Kaneko, Y.; Kawabata, K.; Mori, H.; Kung, M.P.; Kung, H.F. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease. Nucl. Med. Biol., 2005, 32(4), 329-335. (Pubitemid 40692683)
120. Qu, W.; Kung, M.P.; Hou, C.; Benedum, T.E.; Kung, H.F. Novel styrylpyridines as probes for SPECT imaging of amyloid plaques. J. Med. Chem., 2007, 50(9), 2157-2165. (Pubitemid 46683068)
121. Zhang, W.; Kung, M.P.; Oya, S.; Hou, C.; Kung, H.F. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging. Nucl. Med. Biol., 2007, 34(1), 89-97. (Pubitemid 46038150)
122. Choi, S.R.; Golding, G.; Zhuang, Z.; Zhang, W.; Lim, N.; Hefti, F.; Benedum, T.E.; Kilbourn, M.R.; Skovronsky, D.; Kung, H.F. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J. Nucl. Med., 2009, 50(11), 1887-1894.
123. Wong, D.F.; Rosenberg, P.B.; Zhou, Y.; Kumar, A.; Raymont, V.; Ravert, H.T.; Dannals, R.F.; Nandi, A.; Brasic, J.R.; Ye, W.; Hilton, J.; Lyketsos, C.; Kung, H.F.; Joshi, A.D.; Skovronsky, D.M.; Pontecorvo, M.J. In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Florbetapirr Corrected F18). J. Nucl. Med., 2010, 51(6), 913-920.
124. Lin, K.J.; Hsu, W.C.; Hsiao, I.T.; Wey, S.P.; Jin, L.W.; Skovronsky, D.; Wai, Y.Y.; Chang, H.P.; Lo, C.W.; Yao, C.H.; Yen, T.C.; Kung, M.P. Whole-body biodistribution and brain PET imaging with 18FAV-45, a novel amyloid imaging agent-a pilot study. Nucl. Med. Biol., 2010, 37(4), 497-508.
125. Hsiao, I.T.; Huang, C.C.; Hsieh, C.J.; Hsu, W.C.; Wey, S.P.; Yen, T.C.; Kung, M.P.; Lin, K.J. Correlation of early-phase [18F]florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies. Eur. J. Nucl. Med. Mol. Imaging, 2012, 39(4), 613-620.
126. Camus, V.; Payoux, P.; Barre, L.; Desgranges, B.; Voisin, T.; Tauber, C.; La Joie, R.; Tafani, M.; Hommet, C.; Chetelat, G.; Mondon, K.; de La Sayette, V.; Cottier, J.P.; Beaufils, E.; Ribeiro, M.J.; Gissot, V.; Vierron, E.; Vercouillie, J.; Vellas, B.; Eustache, F.; Guilloteau, D. Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur. J. Nucl. Med. Mol. Imaging, 2012, 39(4), 621-631.
127. Rosenberg, P.B.; Wong, D.F.; Edell, S.L.; Ross, J.S.; Joshi, A.D.; Brasic, J.R.; Zhou, Y.; Raymont, V.; Kumar, A.; Ravert, H.T.; Dannals, R.F.; Pontecorvo, M.J.; Skovronsky, D.M.; Lyketsos, C.G. Cognition and amyloid load in alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography. Am. J. Geriatr. Psychiatry, 2013, 21(3), 272-278.
128. Lee, H.J.; Jeong, J.M.; Rai, G.; Lee, Y.S.; Chang, Y.S.; Kim, Y.J.; Kim,
129. Lee, I.; Choe, Y.S.; Choi, J.Y.; Lee, K.H.; Kim, B.T. Synthesis and evaluation of (18)F-labeled styryltriazole and resveratrol derivatives for beta-amyloid plaque imaging. J. Med. Chem., 2012, 55(2), 883-892.
130. Yang, Y.; Jia, H.M.; Liu, B.L. (E)-5-styryl-1H-indole and (E)-6-styrylquinoline derivatives serve as probes for beta-amyloid plaques. Molecules, 2012, 17(4), 4252-4265.
131. Qu, W.; Kung, M.P.; Hou, C.; Jin, L.W.; Kung, H.F. Radioiodinated aza-diphenylacetylenes as potential SPECT imaging agents for beta-amyloid plaque detection. Bioorg. Med. Chem. Lett., 2007, 17(13), 3581-3584. (Pubitemid 46898821)
132. Chandra, R.; Oya, S.; Kung, M.P.; Hou, C.; Jin, L.W.; Kung, H.F. New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques. J. Med. Chem., 2007, 50(10), 2415-2423. (Pubitemid 46799253)
133. Wey, S.P.; Weng, C.C.; Lin, K.J.; Yao, C.H.; Yen, T.C.; Kung, H.F.; Skovronsky, D.; Kung, M.P. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques. Nucl. Med. Biol., 2009, 36(4), 411-417.
134. Zhuang, Z.P.; Kung, M.P.; Hou, C.; Ploessl, K.; Kung, H.F. Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain. Nucl. Med. Biol., 2005, 32(2), 171-184. (Pubitemid 40260669)
135. Lee, C.W.; Kung, M.P.; Hou, C.; Kung, H.F. Dimethylaminofluorenes: ligands for detecting beta-amyloid plaques in the brain. Nucl. Med. Biol., 2003, 30(6), 573-580.
136. Zhang., W.; Kung., M.-P.; Hou., C.; Oya., S.; Skovronsky., D.; Manchanda., R.; Choi., S.-R.; Kung., H. Phenapth and napthphen derivatives as PET imaging agents for Alzheimer's disease. J. Nucl. Med., 2008, 49(Supplement 1), 143P.
137. Cui, M.; Ono, M.; Kimura, H.; Liu, B.; Saji, H. Novel quinoxaline derivatives for in vivo imaging of beta-amyloid plaques in the brain. Bioorg. Med. Chem. Lett., 2011, 21(14), 4193-4196.
138. Yu, P.; Cui, M.; Wang, X.; Zhang, X.; Li, Z.; Yang, Y.; Jia, J.; Zhang, J.; Ono, M.; Saji, H.; Jia, H.; Liu, B. (18)F-labeled 2-phenylquinoxaline derivatives as potential positron emission tomography probes for in vivo imaging of beta-amyloid plaques. Eur. J. Med. Chem., 2012, 57, 51-58.
139. Chandra, R.; Kung, M.P.; Kung, H.F. Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging. Bioorg. Med. Chem. Lett., 2006, 16(5), 1350-1352. (Pubitemid 43148927)
140. Qu, W.; Kung, M.P.; Hou, C.; Oya, S.; Kung, H.F. Quick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease. J. Med. Chem., 2007, 50(14), 3380-3387. (Pubitemid 47065987)
141. Ono, M.; Haratake, M.; Saji, H.; Nakayama, M. Development of novel beta-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole. Bioorg. Med. Chem., 2008, 16(14), 6867-6872.
142. Watanabe, H.; Ono, M.; Ikeoka, R.; Haratake, M.; Saji, H.; Nakayama, M. Synthesis and biological evaluation of radioiodinated 2,5-diphenyl-1,3,4- oxadiazoles for detecting betaamyloid plaques in the brain. Bioorg. Med. Chem., 2009, 17(17), 6402-6406.
143. Okamura, N.; Suemoto, T.; Shimadzu, H.; Suzuki, M.; Shiomitsu, T.; Akatsu, H.; Yamamoto, T.; Staufenbiel, M.; Yanai, K.; Arai, H.; Sasaki, H.; Kudo, Y.; Sawada, T. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain. J. Neurosci., 2004, 24(10), 2535-2541. (Pubitemid 38327966)
144. Okamura, N.; Suemoto, T.; Shiomitsu, T.; Suzuki, M.; Shimadzu, H.; Akatsu, H.; Yamamoto, T.; Arai, H.; Sasaki, H.; Yanai, K.; Staufenbiel, M.; Kudo, Y.; Sawada, T. A novel imaging probe for in vivo detection of neuritic and diffuse amyloid plaques in the brain. J. Mol. Neurosci., 2004, 24(2), 247-255. (Pubitemid 41359152)
145. Shimadzu, H.; Suemoto, T.; Suzuki, M.; Shiomitsu, T.; Okamura, N.; Kudo, Y.; Sawada, T. Novel probes for imaging amyloid-β: F-18 and C-11 labeling of 2-(4-aminostyryl)benzoxazole derivatives. J. Labelled Compd. Radiopharm., 2004, 47(3), 181-190. (Pubitemid 38525291)
146. Okamura, N.; Furumoto, S.; Funaki, Y.; Suemoto, T.; Kato, M.; Ishikawa, Y.; Ito, S.; Akatsu, H.; Yamamoto, T.; Sawada, T.; Arai, H.; Kudo, Y.; Yanai, K. Binding and safety profile of novel benzoxazole derivative for in vivo imaging of amyloid deposits in Alzheimer's disease. Geriatr. Gerontol. Int., 2007, 7(4), 393-400.
147. Kudo, Y.; Okamura, N.; Furumoto, S.; Tashiro, M.; Furukawa, K.; Maruyama, M.; Itoh, M.; Iwata, R.; Yanai, K.; Arai, H. 2-(2-2-Dimethylaminothiazol-5- ylethenyl)-6-(2-fluoroethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J. Nucl. Med., 2007, 48(4), 553-561. (Pubitemid 47571409)
148. Cui, M.C.; Li, Z.J.; Tang, R.K.; Liu, B.L. Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for beta-amyloid plaques in Alzheimer's disease. Bioorg. Med. Chem., 2010, 18(7), 2777-2784.
149. Cui, M.; Li, Z.; Tang, R.; Jia, H.; Liu, B. Novel (E)-5-styryl-2,2'- bithiophene derivatives as ligands for beta-amyloid plaques. Eur. J. Med. Chem., 2011, 46(7), 2908-2916.
150. Alagille, D.; DaCosta, H.; Baldwin, R.M.; Tamagnan, G.D. 2-Arylimidazo2,1-bbenzothiazoles: a new family of amyloid binding agents with potential for PET and SPECT imaging of Alzheimer's brain. Bioorg. Med. Chem. Lett., 2011, 21(10), 2966-2968.
151. Yousefi, B.H.; Manook, A.; Drzezga, A.; von Reutern, B.; Schwaiger, M.; Wester, H.J.; Henriksen, G. Synthesis and evaluation of [11C]-labeled imidazo2,1-bbenzothiazoles (IBTs) as PET tracers for imaging beta-amyloid plaques in Alzheimer's disease. J. Med. Chem., 2011, 54(4), 949-956.
152. Yousefi, B.H.; Drzezga, A.; Reutern, B.v.; Manook, A.; Schwaiger, M.; Wester, H.-J.r.; Henriksen, G. A 18F-labeled imidazo[2,1-b]benzothiazole (IBT) for high-contrast PET imagingof β-amyloid plaques. ACS Med. Chem. Lett., 2011, 2(9), 673-677.
153. Kikuzaki, H.; Nakatani, N. Antioxidant effects of some ginger constituents. J. Food Sci., 1993, 58(6), 1407-1410.
154. Chan, M.M.; Huang, H.I.; Fenton, M.R.; Fong, D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem. Pharmacol., 1998, 55(12), 1955-1962. (Pubitemid 28477465)
155. Yang, F.; Lim, G.P.; Begum, A.N.; Ubeda, O.J.; Simmons, M.R.; Ambegaokar, S.S.; Chen, P.P.; Kayed, R.; Glabe, C.G.; Frautschy, S.A.; Cole, G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem., 2005, 280(7), 5892-5901. (Pubitemid 40280072)
156. Ryu, E.K.; Choe, Y.S.; Lee, K.H.; Choi, Y.; Kim, B.T. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. J. Med. Chem., 2006, 49(20), 6111-6119. (Pubitemid 44484955)
157. Lee, I.; Yang, J.; Lee, J.H.; Choe, Y.S. Synthesis and evaluation of 1-(4-(18)Ffluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for beta-amyloid plaque imaging. Bioorg. Med. Chem. Lett., 2011, 21(19), 5765-5769.
158. Cui, M.; Ono, M.; Kimura, H.; Liu, B.; Saji, H. Synthesis and structure-affinity relationships of novel dibenzylideneacetone derivatives as probes for beta-amyloid plaques. J. Med. Chem., 2011, 54(7), 2225-2240.
159. Ono, M.; Yoshida, N.; Ishibashi, K.; Haratake, M.; Arano, Y.; Mori, H.; Nakayama, M. Radioiodinated flavones for in vivo imaging of beta-amyloid plaques in the brain. J. Med. Chem., 2005, 48(23), 7253-7260. (Pubitemid 41743639)
160. Ono, M.; Watanabe, R.; Kawashima, H.; Kawai, T.; Watanabe, H.; Haratake, M.; Saji, H.; Nakayama, M. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains. Bioorg. Med. Chem., 2009, 17(5), 2069-2076.
161. Ono, M.; Maya, Y.; Haratake, M.; Nakayama, M. Synthesis and characterization of styrylchromone derivatives as beta-amyloid imaging agents. Bioorg. Med. Chem., 2007, 15(1), 444-450. (Pubitemid 44738560)
162. Ono, M.; Haratake, M.; Mori, H.; Nakayama, M. Novel chalcones as probes for in vivo imaging of beta-amyloid plaques in Alzheimer's brains. Bioorg. Med. Chem., 2007, 15(21), 6802-6809. (Pubitemid 47385239)
163. Ono, M.; Watanabe, R.; Kawashima, H.; Cheng, Y.; Kimura, H.; Watanabe, H.; Haratake, M.; Saji, H.; Nakayama, M. Fluoropegylated chalcones as positron emission tomography probes for in vivo imaging of beta-amyloid plaques in Alzheimer's disease. J. Med. Chem., 2009, 52(20), 6394-6401.
164. Ono, M.; Watanabe, H.; Watanabe, R.; Haratake, M.; Nakayama, M.; Saji, H. Diphenylpropynone derivatives as probes for imaging beta-amyloid plaques in Alzheimer's brains. Bioorg. Med. Chem. Lett., 2011, 21(1), 117-120.
165. Ono, M.; Maya, Y.; Haratake, M.; Ito, K.; Mori, H.; Nakayama, M. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease. Biochem. Biophys. Res. Commun., 2007, 361(1), 116-121. (Pubitemid 47102275)
166. Maya, Y.; Ono, M.; Watanabe, H.; Haratake, M.; Saji, H.; Nakayama, M. Novel radioiodinated aurones as probes for SPECT imaging of beta-amyloid plaques in the brain. Bioconjug. Chem., 2009, 20(1), 95-101.
167. Watanabe, H.; Ono, M.; Kimura, H.; Kagawa, S.; Nishii, R.; Fuchigami, T.; Haratake, M.; Nakayama, M.; Saji, H. A dual fluorinated and iodinated radiotracer for PET and SPECT imaging of beta-amyloid plaques in the brain. Bioorg. Med. Chem. Lett., 2011, 21(21), 6519-6522.
168. Cui, M.; Ono, M.; Kimura, H.; Liu, B.; Saji, H. Synthesis and evaluation of benzofuran-2-yl(phenyl)methanone derivatives as ligands for beta-amyloid plaques. Bioorg. Med. Chem., 2011, 19(13), 4148-4153.
169. Qiao, J.P.; Gan, C.S.; Wang, C.W.; Ge, J.F.; Nan, D.D.; Pan, J.; Zhou, J.N. Novel Indanone Derivatives As Potential Imaging Probes for Beta-amyloid Plaques in the Brain. ChemBioChem, 2012, 13(11), 1652-1662.
170. Ono, M.; Hori, M.; Haratake, M.; Tomiyama, T.; Mori, H.; Nakayama, M. Structure-activity relationship of chalcones and related derivatives as ligands for detecting of beta-amyloid plaques in the brain. Bioorg. Med. Chem., 2007, 15(19), 6388-6396. (Pubitemid 47212733)
171. Suemoto, T.; Okamura, N.; Shiomitsu, T.; Suzuki, M.; Shimadzu, H.; Akatsu, H.; Yamamoto, T.; Kudo, Y.; Sawada, T. In vivo labeling of amyloid with BF-108. Neurosci. Res., 2004, 48(1), 65-74. (Pubitemid 37543770)
172. Shimadzu, H.; Suemoto, T.; Suzuki, M.; Shiomitsu, T.; Okamura, N.; Kudo, Y.; Sawada, T. A novel probe for imaging amyloid-β: Synthesis of F-18 labelled BF-108, an acridine orange analog. J. Labelled Compd. Radiopharm., 2003, 46(8), 765-772. (Pubitemid 36890064)
173. Fuchigami, T.; Kobashi, N.; Haratake, M.; Kawasaki, M.; Nakayama, M. Synthesis and biological evaluation of radioiodinated quinacrine-based derivatives for SPECT imaging of Abeta plaques. Eur. J. Med. Chem., 2013, 60, 469-478.
174. Lee, H.J.; Lim, S.J.; Oh, S.J.; Moon, D.H.; Kim, D.J.; Tae, J.; Yoo, K.H. Isoindol-1,3-dione and isoindol-1-one derivatives with high binding affinity to beta-amyloid fibrils. Bioorg. Med. Chem. Lett., 2008, 18(5), 1628-1631. (Pubitemid 351324869)
175. Lee, J.H.; Byeon, S.R.; Kim, Y.; Lim, S.J.; Oh, S.J.; Moon, D.H.; Yoo, K.H.; Chung, B.Y.; Kim, D.J. (18)F-labeled isoindol-1-one and isoindol-1,3-dione derivatives as potential PET imaging agents for detection of beta-amyloid fibrils. Bioorg. Med. Chem. Lett., 2008, 18(20), 5701-5704.
176. Duan, X.H.; Qiao, J.P.; Yang, Y.; Cui, M.C.; Zhou, J.N.; Liu, B.L. Novel anilinophthalimide derivatives as potential probes for betaamyloid plaque in the brain. Bioorg. Med. Chem., 2010, 18(3), 1337-1343.
177. Brockschnieder, D.; Schmitt-Willich, H.; Heinrich, T.; Varrone, A.; Gulyas, B.; Toth, M.; Andersson, J.; Boemer, U.; Krause, S.; Friebe, M.; Dinkelborg, L.; Halldin, C.; Dyrks, T. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-beta. J. Nucl. Med., 2012, 53(11), 1794-1801.
178. Jurisson, S.S.; Lydon, J.D. Potential technetium small molecule radiopharmaceuticals. Chem. Rev., 1999, 99(9), 2205-2218.
179. Hom, R.K.; Katzenellenbogen, J.A. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results. Nucl. Med. Biol., 1997, 24(6), 485-498. (Pubitemid 27405014)
180. Johannsen, B.; Pietzsch, H.J. Development of technetium-99mbased CNS receptor ligands: have there been any advances? Eur. J. Nucl. Med. Mol. Imaging, 2002, 29(2), 263-275.
181. Han, H.; Cho, C.-G.; Lansbury, P.T. Technetium complexes for the quantitation of brain amyloid. J. Am. Chem. Soc., 1996, 118(18), 4506-4507. (Pubitemid 26167578)
182. Zhen, W.; Han, H.; Anguiano, M.; Lemere, C.A.; Cho, C.G.; Lansbury, P.T., Jr. Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain. J. Med. Chem., 1999, 42(15), 2805-2815. (Pubitemid 29370425)
183. Dezutter, N.A.; Dom, R.J.; de Groot, T.J.; Bormans, G.M.; Verbruggen, A.M. 99mTc-MAMA-chrysamine G, a probe for betaamyloid protein of Alzheimer's disease. Eur. J. Nucl. Med., 1999, 26(11), 1392-1399. (Pubitemid 29515599)
184. Dezutter, N.A.; Landman, W.J.; Jager, P.L.; de Groot, T.J.; Dupont, P.J.; Tooten, P.C.; Zekarias, B.; Gruys, E.; Verbruggen, A.M. Evaluation of 99mTc-MAMA-chrysamine G As An in Vivo Probe for Amyloidosis. Amyloid, 2001, 8(3), 202-214. (Pubitemid 32916083)
185. Zhuang, Z.-P.; Kung, M.-P.; Ono, M.; Hou, C.; Kung, H.F. Syntheses of two potential ligands for Tc-99m labeling as diagnosis agents of alzheimer's disease. Chin. J. Chem., 2003, 21(7), 824-832.
186. Kung., H.F.; Kung, M.-P.; Hou., C.; Zhuang., Z.-P. 99mTc-labeled stilbenes as potential imaging agents for β-amyloid plaques in the brain. J. Labelled Compd. Radiopharm., 2005, 48.
187. Zhang, J.; Zhou, X.; Qin, X. Preparation, quality control and physico-chemical properties of 99mTc-BAT-AV-45. J. Radioanal. Nucl. Chem., 2012, 292(3), 1377-1383.
188. Serdons, K.; Verduyckt, T.; Cleynhens, J.; Terwinghe, C.; Mortelmans, L.; Bormans, G.; Verbruggen, A. Synthesis and evaluation of a 99mTc-BAT- phenylbenzothiazole conjugate as a potential in vivo tracer for visualization of amyloid. Bioorg. Med. Chem. Lett., 2007, 17(22), 6086-6090. (Pubitemid 47559130)
189. Chen, X.; Yu, P.; Zhang, L.; Liu, B. Synthesis and biological evaluation of 99mTc, Re-monoamine-monoamide conjugated to 2-(4-aminophenyl)benzothiazole as potential probes for beta-amyloid plaques in the brain. Bioorg. Med. Chem. Lett., 2008, 18(4), 1442-1445. (Pubitemid 351233032)
190. Serdons, K.; Vanderghinste, D.; Van Eeckhoudt, M.; Cleynhens, J.; de Groot, T.; Bormans, G.; Verbruggen, A. Synthesis and evaluation of two uncharged 99mTc-labeled derivatives of thioflavin-T as potential tracer agents for fibrillar brain amyloid. J. Labelled Compd. Radiopharm., 2009, 52(6), 227-235.
191. Serdons, K.; Verduyckt, T.; Cleynhens, J.; Bormans, G.; Verbruggen, A. Development of 99mTc-thioflavin-T derivatives for detection of systemic amyloidosis. J. Labelled Compd. Radiopharm., 2008, 51(10), 357-367.
192. Lin, K.S.; Debnath, M.L.; Mathis, C.A.; Klunk, W.E. Synthesis and beta-amyloid binding properties of rhenium 2-phenylbenzothiazoles. Bioorg. Med. Chem. Lett., 2009, 19(8), 2258-2262.
193. Pan, J.; Mason, N.S.; Debnath, M.L.; Mathis, C.A.; Klunk, W.E.; Lin, K.S. Design, synthesis and structure-activity relationship of rhenium 2-arylbenzothiazoles as beta-amyloid plaque binding agents. Bioorg. Med. Chem. Lett., 2013, 23(6), 1720-1726.
194. Ono, M.; Fuchi, Y.; Fuchigami, T.; Kobashi, N.; Kimura, H.; Haratake, M.; Saji, H.; Nakayama, M. Novel benzofurans with 99mTc complexes as probes for imaging cerebral β-amyloid plaques. ACS Med. Chem. Lett., 2010, 1(8), 443-447.
195. Ono, M.; Ikeoka, R.; Watanabe, H.; Kimura, H.; Fuchigami, T.; Haratake, M.; Saji, H.; Nakayama, M. Synthesis and evaluation of novel chalcone derivatives with (99m)Tc/Re complexes as potential probes for detection of beta-amyloid plaques. ACS Chem. Neurosci., 2010, 1(9), 598-607.
196. Ono, M.; Ikeoka, R.; Watanabe, H.; Kimura, H.; Fuchigami, T.; Haratake, M.; Saji, H.; Nakayama, M. 99mTc/Re complexes based on flavone and aurone as SPECT probes for imaging cerebral betaamyloid plaques. Bioorg. Med. Chem. Lett., 2010, 20(19), 5743-5748.
197. Cheng, Y.; Ono, M.; Kimura, H.; Ueda, M.; Saji, H. Technetium-99m labeled pyridyl benzofuran derivatives as single photon emission computed tomography imaging probes for beta-amyloid plaques in Alzheimer's brains. J. Med. Chem., 2012, 55(5), 2279-2286.
198. Cui, M.; Tang, R.; Li, Z.; Ren, H.; Liu, B. 99mTc-and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for beta-amyloid plaques. Bioorg. Med. Chem. Lett., 2011, 21(3), 1064-1068.
199. Wang, X.; Cui, M.; Yu, P.; Li, Z.; Yang, Y.; Jia, H.; Liu, B. Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for beta-amyloid plaques in brain. Bioorg. Med. Chem. Lett., 2012, 22(13), 4327-4331.
200. Sagnou, M.; Benaki, D.; Triantis, C.; Tsotakos, T.; Psycharis, V.; Raptopoulou, C.P.; Pirmettis, I.; Papadopoulos, M.; Pelecanou, M. Curcumin as the oo bidentate ligand in "2 + 1" complexes with the [M(CO)3]+ (M = Re, 99mTc) tricarbonyl core for radiodiagnostic applications. Inorg. Chem., 2011, 50(4), 1295-1303.
201. Wenzel, M. Tc-99m-markierung von cymantren-analogen verbindungen mit verschiedenen substituenten-ein neuer zugang zu Tc-99m radiodiagnostika. J. Labelled Compd. Radiopharm., 1992, 31(9), 641-650.
202. Bernard, J.; Ortner, K.; Spingler, B.; Pietzsch, H.J.; Alberto, R. Aqueous synthesis of derivatized cyclopentadienyl complexes of technetium and rhenium directed toward radiopharmaceutical application. Inorg. Chem., 2003, 42(4), 1014-1022.
203. N'Dongo, H.W.; Raposinho, P.D.; Fernandes, C.; Santos, I.; Can, D.; Schmutz, P.; Spingler, B.; Alberto, R. Preparation and biological evaluation of cyclopentadienyl-based 99mTc-complexess (Cp-R)99mTc(CO)3 mimicking benzamides for malignant melanoma targeting. Nucl. Med. Biol., 2010, 37(3), 255-264.
204. Li, Z.; Cui, M.; Dai, J.; Wang, X.; Yu, P.; Yang, Y.; Jia, J.; Fu, H.; Ono, M.; Jia, H.; Saji, H.; Liu, B. Novel cyclopentadienyl tricarbonyl complexes of (99m)Tc mimicking chalcone as potential single-photon emission computed tomography imaging probes for beta-amyloid plaques in brain. J. Med. Chem., 2013, 56(2), 471-482.
205. Li, Q.; Min, J.; Ahn, Y.H.; Namm, J.; Kim, E.M.; Lui, R.; Kim, H.Y.; Ji, Y.; Wu, H.; Wisniewski, T.; Chang, Y.T. Styryl-based Compounds As Potential in Vivo Imaging Agents for Beta-amyloid Plaques. ChemBioChem, 2007, 8(14), 1679-1687. (Pubitemid 47523672)
206. Ono, M.; Hayashi, S.; Kimura, H.; Kawashima, H.; Nakayama, M.; Saji, H. Push-pull benzothiazole derivatives as probes for detecting beta-amyloid plaques in Alzheimer's brains. Bioorg. Med. Chem., 2009, 17(19), 7002-7007.
207. Park, Y.D.; Park, J.H.; Hur, M.G.; Kim, S.W.; Min, J.J.; Park, S.H.; Yoo, Y.J.; Yoon, Y.J.; Yang, S.D. Fluorescent 2-styrylpyridazin-3(2H)-one derivatives as probes targeting amyloid-beta plaques in Alzheimer's disease. Bioorg. Med. Chem. Lett., 2012, 22(12), 4106-4110.
208. Chang, W.M.; Dakanali, M.; Capule, C.C.; Sigurdson, C.J.; Yang, J.; Theodorakis, E.A. ANCA: a family of fluorescent probes that bind and stain amyloid plaques in human tissue. ACS Chem. Neurosci., 2011, 2(5), 249-255.
209. Gemma, S.; Colombo, L.; Forloni, G.; Savini, L.; Fracasso, C.; Caccia, S.; Salmona, M.; Brindisi, M.; Joshi, B.P.; Tripaldi, P.; Giorgi, G.; Taglialatela-Scafati, O.; Novellino, E.; Fiorini, I.; Campiani, G.; Butini, S. Pyrroloquinoxaline hydrazones as fluorescent probes for amyloid fibrils. Org. Biomol. Chem., 2011, 9(14), 5137-5148.
210. Liu, K.; Guo, T.L.; Chojnacki, J.; Lee, H.G.; Wang, X.; Siedlak, S.L.; Rao, W.; Zhu, X.; Zhang, S. Bivalent ligand containing curcumin and cholesterol as fluorescence probe for Abeta plaques in Alzheimer's disease. ACS Chem. Neurosci., 2012, 3(2), 141-146.
211. Nilsson, K.P.; Aslund, A.; Berg, I.; Nystrom, S.; Konradsson, P.; Herland, A.; Inganas, O.; Stabo-Eeg, F.; Lindgren, M.; Westermark, G.T.; Lannfelt, L.; Nilsson, L.N.; Hammarstrom, P. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. ACS Chem. Biol., 2007, 2(8), 553-560. (Pubitemid 350011326)
212. Aslund, A.; Sigurdson, C.J.; Klingstedt, T.; Grathwohl, S.; Bolmont, T.; Dickstein, D.L.; Glimsdal, E.; Prokop, S.; Lindgren, M.; Konradsson, P.; Holtzman, D.M.; Hof, P.R.; Heppner, F.L.; Gandy, S.; Jucker, M.; Aguzzi, A.; Hammarstrom, P.; Nilsson, K.P. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem. Biol., 2009, 4(8), 673-684.
213. Licha, K.; Olbrich, C. Optical imaging in drug discovery and diagnostic applications. Adv. Drug Deliv. Rev., 2005, 57(8), 1087-1108. (Pubitemid 40797571)
214. Li, Q.; Lee, J.S.; Ha, C.; Park, C.B.; Yang, G.; Gan, W.B.; Chang, Y.T. Solid-phase synthesis of styryl dyes and their application as amyloid sensors. Angew. Chem. Int. Ed. Engl., 2004, 43(46), 6331-6335. (Pubitemid 40029464)
215. Hintersteiner, M.; Enz, A.; Frey, P.; Jaton, A.L.; Kinzy, W.; Kneuer, R.; Neumann, U.; Rudin, M.; Staufenbiel, M.; Stoeckli, M.; Wiederhold, K.H.; Gremlich, H.U. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazinederivative probe. Nat. Biotechnol., 2005, 23(5), 577-583. (Pubitemid 41724896)
216. Ono, M.; Ishikawa, M.; Kimura, H.; Hayashi, S.; Matsumura, K.; Watanabe, H.; Shimizu, Y.; Cheng, Y.; Cui, M.; Kawashima, H.; Saji, H. Development of dual functional SPECT/fluorescent probes for imaging cerebral beta-amyloid plaques. Bioorg. Med. Chem. Lett., 2010, 20(13), 3885-3888.
217. Ono, M.; Watanabe, H.; Kimura, H.; Saji, H. BODIPY-based molecular probe for imaging of cerebral beta-amyloid plaques. ACS Chem. Neurosci., 2012, 3(4), 319-324.
218. Antoni, G.; Lubberink, M.; Estrada, S.; Axelsson, J.; Carlson, K.; Lindsjo, L.; Kero, T.; Langstrom, B.; Granstam, S.O.; Rosengren, S.; Vedin, O.; Wassberg, C.; Wikstrom, G.; Westermark, P.; Sorensen, J. In vivo visualization of amyloid deposits in the heart with [11C]-PIB and PET. J. Nucl. Med., 2013, 54(2), 213-220.
219. Song, P.J.; Bernard, S.; Sarradin, P.; Vergote, J.; Barc, C.; Chalon, S.; Kung, M.P.; Kung, H.F.; Guilloteau, D. IMPY, a potential betaamyloid imaging probe for detection of prion deposits in scrapieinfected mice. Nucl. Med. Biol., 2008, 35(2), 197-201.
220. Fodero-Tavoletti, M.T.; Smith, D.P.; McLean, C.A.; Adlard, P.A.; Barnham, K.J.; Foster, L.E.; Leone, L.; Perez, K.; Cortes, M.; Culvenor, J.G.; Li, Q.X.; Laughton, K.M.; Rowe, C.C.; Masters, C.L.; Cappai, R.; Villemagne, V.L. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. J. Neurosci., 2007, 27(39), 10365-10371. (Pubitemid 47502018)
221. Edison, P.; Rowe, C.C.; Rinne, J.O.; Ng, S.; Ahmed, I.; Kemppainen, N.; Villemagne, V.L.; O'Keefe, G.; Nagren, K.; Chaudhury, K.R.; Masters, C.L.; Brooks, D.J. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J. Neurol. Neurosurg. Psychiatry, 2008, 79(12), 1331-1338.
222. Ly, J.V.; Donnan, G.A.; Villemagne, V.L.; Zavala, J.A.; Ma, H.; O'Keefe, G.; Gong, S.J.; Gunawan, R.M.; Saunder, T.; Ackerman, U.; Tochon-Danguy, H.; Churilov, L.; Phan, T.G.; Rowe, C.C. [11C]PIB Binding Is Increased in Patients with Cerebral Amyloid Angiopathy-related Hemorrhage. Neurology, 2010, 74(6), 487-493.
223. Zha, Z.; Choi, S.R.; Ploessl, K.; Lieberman, B.P.; Qu, W.; Hefti, F.; Mintun, M.; Skovronsky, D.; Kung, H.F. Multidentate 18Fpolypegylated styrylpyridines as imaging agents for aβ plaques in cerebral amyloid angiopathy (CAA). J. Med. Chem., 2011, 54(23), 8085-8098.